24/7 Market News Snapshot 21 January, 2025 – Helius Medical Technologies, Inc. Class A Common Stock (DE) (NASDAQ:HSDT)

January 21, 2025

DENVER, Colo., 21 January, 2025 (247marketnews.com) – (NASDAQ:HSDT) are discussed in this article.
Helius Medical Technologies, Inc. is experiencing a notable surge in its stock price, with shares climbing over 82.95% to $1.374 in pre-market trading, following a strong trading volume of 39.36 million shares. This robust increase reflects heightened investor interest and positions Helius as an emerging player in the medical technology sector, particularly focused on neurological therapies.

Concurrently, the company has announced impressive advancements in its stroke registrational program involving the Portable Neuromodulation Stimulator (PoNS®), which aims to assist stroke survivors in improving balance and gait deficits. As of December 31, 2024, Helius has successfully enrolled 128 participants, surpassing its initial goal of 90, with expectations to reach a maximum enrollment of 150 by the end of January 2025. This initiative addresses a pressing need, given that over 7 million stroke survivors in the U.S. contend with mobility challenges.

Dane Andreeff, President and CEO, emphasized the significance of this program, stating, “Our focus on addressing gait and balance deficits, the most common disabilities resulting from a stroke, presents a tremendous opportunity for PoNS Therapy®.” The stroke registrational program, which earned Breakthrough Designation from the FDA in 2021, seeks to validate the safety and efficacy of PoNS therapy. It is designed to demonstrate how this innovative device can improve patient mobility, lower fall risks, and sustain benefits following treatment.

With the timeline for FDA submission aimed at the second quarter of 2025, the rapid enrollment progress underscores the strong interest from healthcare providers and a growing demand among patients for effective rehabilitation options. Helius Medical Technologies is steadfast in its mission to enhance the quality of life for individuals affected by neurological disorders, reaffirming its potential within the rehabilitation landscape.

Related news for (HSDT)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.